Metabolic/hypoxial axis predicts tamoxifen resistance in breast cancer

Metabolic/hypoxial axis predicts tamoxifen resistance in breast cancer

Abstract We sought in our cross-sectional study to investigate the role of metabolic/hypoxial axis in the development of tamoxifen (TMX) resistance in BC patients. Quantification of plasma LncRNA Taurine upregulated-1 (TUG-1), miRNA 186-5p (miR-186), serum Sirtuin-3 (SIRT3), Peroxisome Proliferator...

Full description

Bibliographic Details
Main Authors:	Hany N. Azzam, Marwa O. El-Derany, Sara A. Wahdan, Reham M. Faheim, Gouda K. Helal, Ebtehal El-Demerdash
Format:	Article
Language:	English
Published:	Nature Portfolio 2022-09-01
Series:	Scientific Reports
Online Access:	https://doi.org/10.1038/s41598-022-19977-w

Similar Items

Taurine upregulated 1: Prognostic biomarker in breast cancer
by: Hany Azzam, et al.
Published: (2022-12-01)

Hypoxie and Hyperoxia
by: Zinner C, et al.
Published: (2019-05-01)

Diversity and Conservation Through Cultivation of <i>Hypoxis</i> in Africa—A Case Study of <i>Hypoxis hemerocallidea</i>
by: Motiki M Mofokeng, et al.
Published: (2020-03-01)

Direct Acting Antiviral Drugs: Pharmacokinetics and Drug-Drug Interactions
by: Marina Barakat, et al.
Published: (2022-12-01)

Estrategia reproductiva de una hierba perenne: Hypoxis decumbens (Hypoxidaceae)
by: Elena Raimúndez U, et al.
Published: (1998-09-01)

FoxO3a Drives the Metabolic Reprogramming in Tamoxifen-Resistant Breast Cancer Cells Restoring Tamoxifen Sensitivity
by: Marco Fiorillo, et al.
Published: (2023-12-01)

Inhibition of Metabolism as a Therapeutic Option for Tamoxifen-Resistant Breast Cancer Cells
by: Friederike Steifensand, et al.
Published: (2021-09-01)

NADES Compounds Identified in <i>Hypoxis hemerocallidea</i> Corms during Dormancy
by: Motiki M. Mofokeng, et al.
Published: (2022-09-01)

Early and late tamoxifen resistance in breast cancer
by: Abu Rabi Z., et al.
Published: (2010-01-01)

Favipiravir, an antiviral drug, in combination with tamoxifen exerts synergistic effect in tamoxifen-resistant breast cancer cells via hTERT inhibition
by: Sally A. Fahim, et al.
Published: (2024-01-01)

Hyperactivation of MAPK Induces Tamoxifen Resistance in SPRED2-Deficient ERα-Positive Breast Cancer
by: Vasiliki Vafeiadou, et al.
Published: (2022-02-01)

Polymorphisms in Interleukin 13 Signaling and Interacting Genes Predict Advanced Fibrosis and Hepatocellular Carcinoma Development in Non-Alcoholic Steatohepatitis
by: Marwa O. El-Derany
Published: (2020-04-01)

Effects of Combined Pentadecanoic Acid and Tamoxifen Treatment on Tamoxifen Resistance in MCF−7/SC Breast Cancer Cells
by: Ngoc Bao To, et al.
Published: (2022-09-01)

Tamoxifen resistance-related ceRNA network for breast cancer
by: Zipeng Qiao, et al.
Published: (2022-11-01)

Tamoxifen in breast conservation therapy.
by: Lee, K, et al.
Published: (1995)

Vildagliptin restores cognitive function and mitigates hippocampal neuronal apoptosis in cisplatin-induced chemo-brain: Imperative roles of AMPK/Akt/CREB/ BDNF signaling cascades
by: Abdulla M.A. Mahmoud, et al.
Published: (2023-03-01)

HYPOXIS COLLICULATA (HYPOXIDACEAE), A NEW SPECIES FROM MEXICO AND A KEY TO THE AMERICAN SPECIES WITH BLACK SEEDS
by: J. Gabriel S\u00E1nchez-Ken
Published: (2010-01-01)

Epigenetic silencing of SALL2 confers tamoxifen resistance in breast cancer
by: Liping Ye, et al.
Published: (2019-12-01)

Molecular Analysis of Acquired Tamoxifen Resistance in Breast Cancer Cell Line
by: Mansour Abachi, et al.
Published: (2017-06-01)

Epigenetic silencing of SALL2 confers tamoxifen resistance in breast cancer
by: Liping Ye, et al.
Published: (2022-03-01)

TARBP2-Enhanced Resistance during Tamoxifen Treatment in Breast Cancer
by: Ming-Yang Wang, et al.
Published: (2019-02-01)

WITHDRAWN: Tamoxifen for early breast cancer.
by: Clarke, M
Published: (2008)

Human genetic determinants of tamoxifen metabolism
by: Koh, Everett Chier Wei
Published: (2021)

Fatty Acid Synthase Confers Tamoxifen Resistance to ER+/HER2+ Breast Cancer
by: Javier A. Menendez, et al.
Published: (2021-03-01)

Overexpression of BQ323636.1 Modulated AR/IL-8/CXCR1 Axis to Confer Tamoxifen Resistance in ER-Positive Breast Cancer
by: Ho Tsoi, et al.
Published: (2022-01-01)

Identification of potential target genes of honokiol in overcoming breast cancer resistance to tamoxifen
by: Hermawan, Adam, et al.
Published: (2022)

Targeting Ribosome Biogenesis to Combat Tamoxifen Resistance in ER+ve Breast Cancer
by: Ho Tsoi, et al.
Published: (2022-02-01)

Identification of potential target genes of honokiol in overcoming breast cancer resistance to tamoxifen
by: Adam Hermawan, et al.
Published: (2022-12-01)

Tamoxifen-resistant breast cancer cells exhibit reactivity with Wisteria floribunda agglutinin.
by: May Thinzar Hlaing, et al.
Published: (2022-01-01)

LncRNA ATXN8OS enhances tamoxifen resistance in breast cancer
by: Zhang Hongkai, et al.
Published: (2020-12-01)

Tamoxifen induces radioresistance through NRF2-mediated metabolic reprogramming in breast cancer
by: F. V. Naumann, et al.
Published: (2023-02-01)

The benefits and costs of tamoxifen for breast cancer prevention
by: Simon D. Eckermann, et al.
Published: (2003-02-01)

The use of tamoxifen in the treatment and prevention of breast cancer
by: Magdalena Hołowczuk, et al.
Published: (2019-06-01)

The use of tamoxifen in the treatment and prevention of breast cancer
by: Magdalena Hołowczuk, et al.
Published: (2019-06-01)

From Micro to Long: Non-Coding RNAs in Tamoxifen Resistance of Breast Cancer Cells
by: Jéssica Fernanda Barazetti, et al.
Published: (2021-07-01)

Heliocarpus popayanensis Kunth (Malvaceae) tolera a hipoxia do substrato? = Does Heliocarpus popayanensis Kunth (Malvaceae) tolerate substract’s hypoxy?
by: Cristina Moreira Pisicchio, et al.
Published: (2010-04-01)

Bone Marrow Mesenchymal Stem Cells and Their Derived Extracellular Vesicles Attenuate Non-Alcoholic Steatohepatitis-Induced Cardiotoxicity via Modulating Cardiac Mechanisms
by: Marwa O. El-Derany, et al.
Published: (2022-02-01)

Tamoxifen therapy for patients with breast cancer - Authors' reply.
by: Davies, C, et al.
Published: (2013)

Tamoxifen for early breast cancer: an overview of the randomised trials
by: Early Breast Cancer Trialists' Collaborative Group
Published: (1998)

RelB-activated GPX4 inhibits ferroptosis and confers tamoxifen resistance in breast cancer
by: Zhi Xu, et al.
Published: (2023-12-01)